Recursion Pharmaceuticals, Inc.RXRXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 3 | 10↑193.0% | 40↑296.8% | 44↑10.6% | 59↑34.1% |
| Gross Profit | 3 | 10↑193.0% | -9↓185.9% | 1↑115.0% | 14↑955.2% |
| Operating Income | -85 | -183↓116.0% | -246↓34.4% | -350↓42.5% | -479↓36.8% |
| Net Income | -87 | -186↓114.3% | -239↓28.4% | -328↓37.0% | -464↓41.3% |
| EBITDA | -82 | -175↓114.3% | -228↓30.0% | -308↓35.1% | -427↓38.7% |
| EPS Diluted | -0.52 | -1.05↓100.1% | -1.36↓29.5% | -1.58↓16.2% | -1.69↓7.0% |